跳至主要内容
临床试验/NL-OMON24163
NL-OMON24163尚未招募不适用

The role of glutamate and GABA in cognition in subjects with chromosome 22q11.2 copy number variants

azM0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
azM
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • For subjects with 22q11.2 CNVs
  • Confirmed diagnosis of 22q11.2 deletion or duplication syndrome established by FISH, microarray or MLPA analysis.
  • 16 year or older of age and mentally competent (determined by an experienced physician) to give informed consent.
  • No presence of a physical/medical condition that may interfere with the study.
  • No contraindication for MRI.
  • For healthy controls:
  • Healthy subjects will be matched for age and gender.
  • No presence of a physical/medical condition that may interfere with the study.
  • No contraindication for MRI.

排除标准

  • For subjects with 22q11.2 CNVs:
  • Other chromosomal abnormalities.
  • Current substance abuse / dependence.
  • A psychiatric or neurologic disorder.
  • Pregnancy.
  • For Healthy controls:
  • Any chromosomal abnormalities.
  • Current substance abuse / dependence.
  • A psychiatric or neurologic disorder.
  • Pregnancy.

研究者

发起方
azM

相似试验

Glutamate, GABA and cognition in subjects with... | 临床试验